Malignant Retroperitoneal Neoplasm — Trials

Malignant Retroperitoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 23
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (17)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04224948	The PET- Retroperitoneal Sarcoma Study(PET-RPS)	completed	N/A	18	University Health Network, TorontoOTHER	1	Dec 3, 2025	clinicaltrials
NCT05044624	Retroperıtoneal Soft-Tıssue Sarcomas	completed	N/A	18	Istanbul Medeniyet UniversityOTHER	0	Sep 16, 2021	clinicaltrials